SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 8.3% Stake in Inspire Medical Systems Inc.
Beneficial Ownership Report
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have filed an amended Schedule 13G, disclosing a beneficial ownership of 8.3% of Inspire Medical Systems Inc.'s common stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 2,501,034.32 shares of Inspire Medical Systems Inc. common stock.
- This aggregate amount represents 8.3% of the outstanding common stock of Inspire Medical Systems Inc.
- FMR LLC holds sole voting power over 2,499,300.00 shares and sole dispositive power over 2,501,034.32 shares.
- Abigail P. Johnson, as Director, Chairman, and CEO of FMR LLC, is deemed to beneficially own the same 2,501,034.32 shares, with sole dispositive power.
- The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- Several FMR LLC subsidiaries, including Fidelity Management & Research Company LLC, are identified as entities that beneficially own shares, with Fidelity Management & Research Company LLC owning 5% or greater of the outstanding shares.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate a positive or negative sentiment regarding the company's performance or outlook. It is a neutral regulatory filing.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by a major institutional investor in a publicly traded company. It reflects FMR LLC's continued or updated investment position in Inspire Medical Systems Inc., a company operating in the medical device sector, specifically known for its sleep apnea solutions. Such disclosures provide transparency regarding significant institutional holdings, which can influence market perception of a company's stability and investment appeal.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by a prominent institutional investor like FMR LLC may be viewed positively by other shareholders, signaling confidence in the company's long-term prospects. It also provides transparency regarding major ownership structures.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of Abigail P. Johnson. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end). |
| 2025-02-11 | Date of filing of this Schedule 13G amendment. |
Keywords
Inspire Medical Systems Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Medical Devices, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.